News

Go to navigation
Go to content

The following shows headlines of all news articles published within 12-months, starting from most recent.

Subscribe to RSS news feed

Pages
1
2
3
4
5
Next

- Jul 23, 2008
- AstraZeneca survey: Healthcare professionals leading source of information on company’s prescription savings programs
- Jul 23, 2008
- AstraZeneca and Bristol-Myers Squibb submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes
- Jul 10, 2008
- AstraZeneca supports new PhRMA code on interactions with healthcare providers
- Jul 1, 2008
- Summary Judgment granted for SEROQUEL® patent litigation
- Jun 26, 2008
- AstraZeneca announces senior management changes at biologics business unit, MedImmune
- Jun 24, 2008
- AstraZeneca partners with St. Vincent de Paul Charitable Pharmacy to provide medicine for uninsured
- Jun 17, 2008
- AstraZeneca and Columbia University Medical Center sign strategic research collaboration to develop novel therapeutics for diabetes and obesity
- Jun 7, 2008
- ONGLYZA™ (saxagliptin) demonstrated significant reductions in key measures of glucose control in treatment naïve people with type 2 diabetes
- Jun 4, 2008
- AstraZeneca submits an sNDA for SYMBICORT® for the treatment of asthma in children as young as age six
- Jun 3, 2008
- Nationwide bus tour rolls into Dover urging Americans to join the fight to defeat cancer
- May 30, 2008
- AstraZeneca submits sNDA for NEXIUM® I.V. for peptic ulcer bleed indication
- May 27, 2008
- Study of twins reveals genetic susceptibility to COPD chronic obstructive pulmonary disease
- May 22, 2008
- AstraZeneca supports transparency legislation on payments to healthcare providers
- May 20, 2008
- Study analyzed SYMBICORT® in children with persistent asthma
- May 20, 2008
- New patient satisfaction study with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy in adults with asthma
- May 19, 2008
- New survey reveals Hispanic-Americans are taking steps to better understand and manage GERD
- May 14, 2008
- Working in partnerships to help those in need in Myanmar (Burma) and elsewhere
- May 14, 2008
- FDA approves AstraZeneca’s SEROQUEL® for maintenance treatment in bipolar disorder
- May 13, 2008
- AstraZeneca praises Senate effort to increase FDA funding
- May 8, 2008
- AstraZeneca submits sNDA for SEROQUEL XR™ for the treatment of generalized anxiety disorder – a first for the atypical antipsychotic class of medicines

Pages
1
2
3
4
5
Next

Page tools

Who is AstraZeneca?

Watch this short video to learn who we are and what we do